Journal article · 2026

Discovery of Quinoline-Based Highly Potent and Selective THRβ Agonists for MASLD Treatment

Kean Wang, Lixin Gao, Feiyang Chen, Tao Yin, Dandan Sun, Yi Zang, Hong Liu, Jia Xuan Li, Jiang Wang

Journal of Medicinal Chemistry · Published 5 November 2026 · DOI 10.1021/acs.jmedchem.6c02885

View at the publisherCite this paper

In brief

“Discovery of Quinoline-Based Highly Potent and Selective THRβ Agonists for MASLD Treatment” is a 2026 journal article by Kean Wang and 8 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 0 citations as of 16 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
References
38
Authors
9

Abstract

Metabolic-dysfunction-associated steatohepatitis (MASH) is a progressive metabolic liver disease lacking sufficient clinical therapies. Thyroid hormone receptor β (THRβ), a liver-enriched nuclear receptor, is an attractive therapeutic target. Resmetirom, the first FDA-approved THRβ agonist for MASH, achieves clinical efficacy yet suffers from suboptimal THRβ/THRα selectivity restricting its therapeutic window. We used a scaffold-hopping strategy to design… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Wang, K., Gao, L., Chen, F., Yin, T., Sun, D., Zang, Y., Liu, H., Li, J. X., & Wang, J. (2026). Discovery of Quinoline-Based Highly Potent and Selective THRβ Agonists for MASLD Treatment. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02885

MLA 9

Wang, Kean, et al. “Discovery of Quinoline-Based Highly Potent and Selective THRβ Agonists for MASLD Treatment.” Journal of Medicinal Chemistry, 2026. https://doi.org/10.1021/acs.jmedchem.6c02885.

Chicago

Wang, Kean, Lixin Gao, Feiyang Chen, Tao Yin, Dandan Sun, Yi Zang, Hong Liu, Jia Xuan Li, and Jiang Wang. 2026. “Discovery of Quinoline-Based Highly Potent and Selective THRβ Agonists for MASLD Treatment.” Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02885.

Harvard

Wang, K. et al. (2026) ‘Discovery of Quinoline-Based Highly Potent and Selective THRβ Agonists for MASLD Treatment’, Journal of Medicinal Chemistry. doi:10.1021/acs.jmedchem.6c02885.

IEEE

K. Wang et al., “Discovery of Quinoline-Based Highly Potent and Selective THRβ Agonists for MASLD Treatment,” Journal of Medicinal Chemistry, 2026, doi: 10.1021/acs.jmedchem.6c02885.

BibTeX

@article{wang2026discovery,
  title     = {{Discovery of Quinoline-Based Highly Potent and Selective THRβ Agonists for MASLD Treatment}},
  author    = {Wang, Kean and Gao, Lixin and Chen, Feiyang and Yin, Tao and Sun, Dandan and Zang, Yi and Liu, Hong and Li, Jia Xuan and Wang, Jiang},
  journal   = {Journal of Medicinal Chemistry},
  year      = {2026},
  doi       = {10.1021/acs.jmedchem.6c02885},
  url       = {https://doi.org/10.1021/acs.jmedchem.6c02885}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment

  • nonalcoholic steatohepatitis
  • thyroid hormone receptor beta
  • quinoline derivatives
  • scaffold hopping
  • resmetirom
  • structure-activity relationship
  • hepatic lipid accumulation
  • liver fibrosis

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Wang, K., Gao, L., Chen, F., Yin, T., Sun, D., Zang, Y., Liu, H., Li, J. X., & Wang, J. (2026). Discovery of Quinoline-Based Highly Potent and Selective THRβ Agonists for MASLD Treatment. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02885

How many times has this paper been cited?

0 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Kean Wang, Lixin Gao, Feiyang Chen, Tao Yin, Dandan Sun, Yi Zang, Hong Liu, Jia Xuan Li, Jiang Wang.

What is the DOI of this paper?

10.1021/acs.jmedchem.6c02885, permanently at https://doi.org/10.1021/acs.jmedchem.6c02885. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.